Literature DB >> 7347566

Amikacin sulfate levels in human serum and bile.

R H Bermúdez, A Lugo, C H Ramírez-Ronda, J A Amadeo, J Morales.   

Abstract

Amikacin levels in blood and bile were measured in 10 patients who underwent cholecystectomy and T-tube drainage. Each patient received 500 mg of amikacin intravenously 12 h preoperatively, during surgery, and every 12 h thereafter for four more doses. Average levels of amikacin in bile were 8.3 micrograms/ml at 1 h after the intraoperative dose, with a bile/serum ratio of 0.44. Postoperative doses at 1 h produced levels in bile of 3.8 to 4.2 micrograms/ml, with a bile/serum ratio of 0.15 to 0.22. Levels in bile decreased at a rate lower than levels in blood, and bile/serum ratios increased from 0.54 at 2 h to 0.93 at 12 h. Amikacin accumulated in bile at 6 h after the intravenous dose.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7347566      PMCID: PMC181428          DOI: 10.1128/AAC.19.2.352

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Purification and partial characterization of an antibiotic produced by Myxococcus xanthus.

Authors:  B Vaks; A Zuckerberg; E Rosenberg
Journal:  Can J Microbiol       Date:  1974-02       Impact factor: 2.419

Review 2.  The chemical basis for the action of the vancomycin group of antibiotics.

Authors:  H R Perkins; M Nieto
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

Review 3.  The tetracyclines.

Authors:  C M Kunin
Journal:  Pediatr Clin North Am       Date:  1968-02       Impact factor: 3.278

4.  Gentamicin levels in the human biliary tract.

Authors:  H A Pitt; R B Roberts; W D Johnson
Journal:  J Infect Dis       Date:  1973-03       Impact factor: 5.226

5.  Gentamicin and ampicillin in human bile.

Authors:  T Smithivas; P J Hyams; J J Rahal
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Thermosensitive mutants of E. coli affected in the processes of DNA synthesis and cellular division.

Authors:  Y Hirota; A Ryter; F Jacob
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1968

7.  Biliary excretion of antibiotics.

Authors:  L J Schoenfield
Journal:  N Engl J Med       Date:  1971-05-27       Impact factor: 91.245

8.  Bactericidal action of an antibiotic produced by Myxococcus xanthus.

Authors:  E Rosenberg; B Vaks; A Zuckerberg
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191

9.  [Fundamental and clinical studies on BB-K8 (amikacin), a new semisynthetic aminoglycoside antibiotic (author's transl)].

Authors:  Y Ueda; F Uba; K Go; Y Okamoto; H Okubo
Journal:  Jpn J Antibiot       Date:  1974-06

10.  [Fundamental and clinical studies of amikacin (BB-K8) in surgical field (author's transl)]?

Authors:  K Shibata; M Fugii; N Shinagawa; Y Suzuki
Journal:  Jpn J Antibiot       Date:  1974-10
View more
  2 in total

Review 1.  Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.

Authors:  Rina Mehrotra; Raffaele De Gaudio; Mark Palazzo
Journal:  Intensive Care Med       Date:  2004-11-05       Impact factor: 17.440

Review 2.  Antibiotics in the treatment of biliary infection.

Authors:  J S Dooley; J M Hamilton-Miller; W Brumfitt; S Sherlock
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.